Bersama Zatta Jaya Tbk PT
IDX:ZATA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bersama Zatta Jaya Tbk PT
IDX:ZATA
|
ID |
|
C
|
Concord Biotech Ltd
NSE:CONCORDBIO
|
IN |
|
S
|
Shanxi Lanhua Sci-Tech Venture Co Ltd
SSE:600123
|
CN |
|
Xinfengming Group Co Ltd
SSE:603225
|
CN |
|
S
|
Sumasapo Inc
TSE:9342
|
JP |
|
A
|
Afarak Group Plc
LSE:AFRK
|
FI |
|
Concejo AB (publ)
STO:CNCJO B
|
SE |
|
Oxford Square Capital Corp
NASDAQ:OXSQ
|
US |
|
HMS Networks AB
STO:HMS
|
SE |
|
Triller Group Inc
NASDAQ:ILLR
|
US |
|
Yuke's Co Ltd
TSE:4334
|
JP |
|
O
|
Optimus Finance Ltd
BSE:531254
|
IN |
|
Woojin Plaimm Co Ltd
KRX:049800
|
KR |
Balance Sheet
Balance Sheet Decomposition
Bersama Zatta Jaya Tbk PT
Bersama Zatta Jaya Tbk PT
Balance Sheet
Bersama Zatta Jaya Tbk PT
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
19 774
|
3 301
|
24 478
|
9 597
|
8 822
|
|
| Cash Equivalents |
19 774
|
3 301
|
24 478
|
9 597
|
8 822
|
|
| Total Receivables |
7 651
|
18 328
|
24 071
|
49 552
|
80 455
|
|
| Accounts Receivables |
7 651
|
18 328
|
24 071
|
21 784
|
13 390
|
|
| Other Receivables |
0
|
0
|
0
|
27 767
|
67 065
|
|
| Inventory |
145 257
|
141 462
|
315 581
|
319 867
|
331 847
|
|
| Other Current Assets |
1 554
|
2 290
|
92 709
|
55 619
|
37 919
|
|
| Total Current Assets |
174 236
|
165 382
|
456 839
|
434 635
|
459 043
|
|
| PP&E Net |
176 071
|
161 472
|
265 699
|
254 033
|
228 250
|
|
| PP&E Gross |
0
|
0
|
0
|
254 033
|
228 250
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
112 902
|
144 004
|
|
| Intangible Assets |
775
|
384
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
2 807
|
2 665
|
3 155
|
2 475
|
3 065
|
|
| Total Assets |
353 889
N/A
|
329 903
-7%
|
725 693
+120%
|
691 143
-5%
|
690 358
0%
|
|
| Liabilities | ||||||
| Accounts Payable |
41 668
|
22 305
|
9 075
|
15 171
|
16 057
|
|
| Accrued Liabilities |
0
|
10 717
|
9 914
|
9 966
|
12 998
|
|
| Short-Term Debt |
183 218
|
153 396
|
9 800
|
0
|
8 500
|
|
| Current Portion of Long-Term Debt |
2 077
|
3 023
|
436
|
17 415
|
16 353
|
|
| Other Current Liabilities |
50 568
|
57 174
|
27 842
|
21 946
|
23 436
|
|
| Total Current Liabilities |
277 531
|
246 614
|
57 067
|
64 498
|
77 344
|
|
| Long-Term Debt |
938
|
12 308
|
154 736
|
52 244
|
37 843
|
|
| Minority Interest |
704
|
1 099
|
0
|
0
|
0
|
|
| Other Liabilities |
8 966
|
1 953
|
1 951
|
52 417
|
50 984
|
|
| Total Liabilities |
288 139
N/A
|
261 974
-9%
|
213 754
-18%
|
169 159
-21%
|
166 172
-2%
|
|
| Equity | ||||||
| Common Stock |
67 000
|
67 000
|
424 800
|
424 800
|
424 800
|
|
| Retained Earnings |
3 186
|
834
|
4 935
|
14 896
|
17 048
|
|
| Additional Paid In Capital |
0
|
0
|
80 747
|
80 747
|
80 747
|
|
| Other Equity |
1 937
|
1 762
|
1 457
|
1 541
|
1 592
|
|
| Total Equity |
65 751
N/A
|
67 929
+3%
|
511 939
+654%
|
521 984
+2%
|
524 187
+0%
|
|
| Total Liabilities & Equity |
353 889
N/A
|
329 903
-7%
|
725 693
+120%
|
691 143
-5%
|
690 358
0%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
8 496
|
8 496
|
8 496
|
8 496
|
8 496
|
|